Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790684 · ClinicalTrials.gov registry record · Phase 1
A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects
A Phase 1 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02790684 is a Phase 1 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 12 participants.
The verdict
NCT02790684, a Phase 1 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a Phase 1, open-label, single-center, non-randomized study to assess the mass balance of a single oral dose of DS-8500a in healthy male subjects, 18 years (y) to 60 y of age, inclusive. The radiolabeled investigational medicinal product will be administered to 12 healthy male subjects in 2 cohorts of 6 subjects each.
Interventions
- DRUG DS-8500a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02790684
The ClinicalTrials.gov registry entry for NCT02790684 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DS-8500a is the first listed.
NCT02790684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02790684 about?
NCT02790684 is a clinical study titled "A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects". This is a Phase 1, open-label, single-center, non-randomized study to assess the mass balance of a single oral dose of DS-8500a in healthy male subjects, 18 years (y) to 60 y of age, inclusive. The radiolabeled investigational medicinal product will be administered to 12 healthy male subjects in 2 c...
What is the current status of trial NCT02790684?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02790684?
The interventions under investigation include: DS-8500a (DRUG).
Who is sponsoring clinical trial NCT02790684?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.